Committee Composition

	Audit Committee	Nominating and Governance Committee	Compensation Committee
Dan W. Gladney		Nominating and Governance Committee
Gary D. Blackford	Audit Committee	Nominating and Governance Committee	Compensation Committee
Lori C. McDougal	Audit Committee		Compensation Committee
Arda M. Minocherhomjee, Ph.D.	Audit Committee	Nominating and Governance Committee	Compensation Committee

= Chairperson = Member = Chairman of the Board

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Daniel Kontoh-Boateng
Vice President
The Ruth Group
646-536-7028/7019
dboateng@theruthgroup.com

PRINT PAGE

EMAIL PAGE

Committee Composition

Committee Composition

Overview

Events and Presentations

Press Releases

SEC Filings

Stock Information

Management

Corporate Governance

Investor FAQs

Email Alerts